Pfizer Consumer Healthcare Sustainability Profile
Pfizer Consumer Healthcare, a division of the renowned pharmaceutical giant Pfizer Inc., is headquartered in the United States and operates extensively across North America and Europe. Founded in the late 19th century, the company has established itself as a leader in the consumer healthcare industry, focusing on over-the-counter (OTC) products that enhance everyday health and well-being. With a diverse portfolio that includes well-known brands such as Preparation H, Advil, and Centrum, Pfizer Consumer Healthcare is committed to delivering innovative solutions that meet the needs of consumers. Their products are distinguished by their efficacy and trusted formulations, making them a preferred choice for millions. Recognised for its strong market position, Pfizer Consumer Healthcare continues to achieve notable milestones in product development and consumer engagement, solidifying its reputation as a key player in the global healthcare landscape.
DitchCarbon Score
How does Pfizer Consumer Healthcare's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Pfizer Consumer Healthcare's score of 84 is higher than 90% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Pfizer Consumer Healthcare, headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. However, the company is part of a broader corporate family, with emissions data and climate commitments cascaded from its parent organisation, Pfizer Inc. Pfizer Inc. has established various climate initiatives, including Science Based Targets Initiative (SBTi) commitments, which aim to significantly reduce greenhouse gas emissions across its operations. These targets are part of a comprehensive strategy to address climate change and enhance sustainability within the healthcare sector. While specific reduction targets for Pfizer Consumer Healthcare are not detailed, the overarching commitments from Pfizer Inc. reflect a strong dedication to reducing carbon footprints and promoting environmental responsibility. The company is actively engaged in initiatives such as RE100 and CDP, which further underscore its commitment to renewable energy and transparency in climate reporting. In summary, while Pfizer Consumer Healthcare does not provide specific emissions data, it benefits from the climate commitments and initiatives of Pfizer Inc., positioning itself within a framework of corporate responsibility towards climate action.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 964,846,000 | - | - | - | - | - | - | - | 000,000,000 | - | - | - | 000,000,000 |
| Scope 2 | 883,814,000 | - | - | - | - | - | - | - | 000,000,000 | - | - | - | 000,000,000 |
| Scope 3 | - | - | - | - | - | - | - | 000,000,000 | 0,000,000,000 | 00,000,000 | 00,000,000 | 000,000,000 | 0,000,000,000 |
How Carbon Intensive is Pfizer Consumer Healthcare's Industry?
How Carbon Intensive is Pfizer Consumer Healthcare's Location?
Pfizer Consumer Healthcare's Scope 3 Categories Breakdown
Pfizer Consumer Healthcare's Scope 3 emissions, which increased significantly last year and increased by approximately 821% since 2019, demonstrating supply chain emissions tracking. Most of their carbon footprint comes from suppliers and value chain emissions, with Scope 3 emissions accounting for 77% of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 79% of Scope 3 emissions.
Top Scope 3 Categories
Pfizer Consumer Healthcare's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Pfizer Consumer Healthcare has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
